BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, February 10, 2026
Home
»
Newsletters
» BioWorld MedTech
BioWorld MedTech
April 13, 2016
View Archived Issues
Atricure probes underpenetrated AF market with latest FDA clearance
Flexibility is the key differentiator of Atricure Inc.'s newest FDA-cleared device. The company launched the Cryoform cryoablation probe in Europe last year under a CE mark and now has an FDA 510(k) clearance for the U.S. market.
Read More
Forbion closes third venture fund at $208M; eyes on early stage
Read More
PAD awareness still an issue for doctors
Read More
ODAC: Rociletinib doesn't rise to the accelerated approval challenge
Read More
Singapore zeroes in on med-tech as a viable growth opportunity
Read More
Other news to note
Read More
Financings
Read More
Appointments and advancements
Read More
Daily M&A
Read More
Product Briefs
Read More
Keeping you up to date on recent developments in oncology
Read More
